However, here is some general guidance on factors that would determine the potential place of a new antidiabetic medication like CT-996 in the therapeutic landscape, based on common considerations: Efficacy : CT-996 would need to demonstrate substantial efficacy in reducing blood glucose levels, indicated by parameters such as HbA1c reductions
Still, major trials on two GLP-1 drugs (tirzepatide and semaglutide) offer some information about the impact of these medications on muscle loss, according to a 2025 analysis in Obesity Reviews
[00:20:47] Emily Field: The research points to three major strategies, fuel the body with enough protein, challenge the body with strength training, and make sure the pace of weight loss is something your body can actually support, because together those are the signals that tell your body to keep the muscle
Includes the same level of medical oversight and delivery, with premium-tier pricing
Now, press down firmly with the palm of your hand
